Yok-Ai Que

Has grant

University Name
Country flag
Switzerland

Research Interests

Explore related searches

Recent Grants

Grant: Open

What’s in a dose? Refining phage and antibiotic dosing for effective treatment of multidrug resistant bacterial infections

Open Date: 2022-11-01

Close Date: 2026-10-31

Grant: Close

Phage Therapy in Humans: Overview on Current Concepts in Europe and the Middle East

Open Date: 2022-08-01

Close Date: 2022-10-31

Grant: Close

Prophylaxis and Treatment of Staphylococcus spp. Intravascular and Extravascular Infections with Bacteriophages

Open Date: 2018-02-01

Close Date: 2022-01-31

Grant: Close

Prophylaxis and Treatment of Staphylococcus spp. Pneumonia and Catheter-related Infections with Bacteriophages

Open Date: 2018-01-01

Close Date: 2019-01-01

Grant: Close

In silico prediction of phage-bacteria infection networks as a tool to implement personalized phage therapy

Open Date: 2016-07-01

Close Date: 2019-12-31

Articles (10)

Ten‐year retrospective cohort analysis of ventricular assist device infections

Background The number of patients treated by ventricular assist devices (VAD) and the duration of VAD treatment is increasing. One of the main complications in terms of morbidity and mortality for VAD patients are microbial infections. With this study, we aimed to investigate the epidemiology and microbiological characteristics of infections occurring in a VAD population to identify modifiable factors. Methods We retrospectively analyzed patient characteristics, treatments and outcomes of VAD‐specific/related infections. All patients implanted in our institution with a continuous flow VAD between January 2009 and January 2019 were included. Risk factors for VAD infection were assessed using simple and multiple linear regressions. Results Of the 104 patients screened, 99 were included in the analysis, the majority of which were men (78%). At implantation, the mean age was 56 years and the median time on VAD support was 541 days. The overall infection rate per year per patient was 1.4. Forty‐seven patients (60%) suffered from VAD‐specific/related infection. Half of all infection episodes occurred in the first 4 months but the proportion of VAD‐specific/related infection was higher after the first 4 months (74% of all infection). Using regression models, no patient specific risk factors were associated with VAD‐specific/related infections. Conclusion No predictive factors for infection during VAD support were identified in this study. By extension, diabetes, renal insufficiency, age or high BMI are not sufficient to deny a patient access to ventricular support.

Year:

2022

Parallel Evolution of Pseudomonas aeruginosa during a Prolonged ICU-Infection Outbreak

Pseudomonas aeruginosa is a Gram-negative pathogen causing infections in acutely burned patients. The precise mechanisms required for the establishment of infection in the burn setting, and adaptive traits underpinning prolonged outbreaks are not known.

Year:

2022

Collaborators (14)

Renald Meçani

Medical University of Graz

AUSTRIA

Amy Tsurumi

Assistant Professor (2022-), Instructor (2019-22), Postdoc Fellow (2012-19)

Massachusetts General Hospital

UNITED STATES

Pierre-Olivier Bridevaux

Professeur titualaire

Université de Genève

SWITZERLAND

Sebastian Robert Ott

Head of Departmebnt

St. Claraspital

SWITZERLAND

André Moser

University of Bern

SWITZERLAND

Martin Brutsche

Prof.

Kantonsspital St. Gallen

SWITZERLAND

Bruno Schnegg

-

SWITZERLAND

Pedro David Wendel Garcia

University Hospital of Zurich

SWITZERLAND

Christophe von Garnier

Head

Lausanne University Hospital

SWITZERLAND

Taulant Muka

Stanford University

UNITED STATES

PETEK EYLUL TANERI

Ollscoil na Gaillimhe – University of Galway

IRELAND

Katja Schlegel

University of Bern

SWITZERLAND

Sabina A. Guler

-

SWITZERLAND

Marco Mancinetti

University of Fribourg

SWITZERLAND
Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI